Transgene Biotek Ltd — Insider Trade, 26-06-2025: Insider Trading / SAST

Transgene Biotek has announced a board meeting on the un-audited financial results for the quarter ended June 30, 2025. The company has also declared closure of its trading window for all directors, key managerial personnel, and designated employees effective from July 1, 2025, until 48 hours after the financial results are published. This measure restricts trading activity to maintain compliance and prevent insider trading ahead of the results announcement, ensuring fair market practices for shareholders.